Pakistan Pharmaceuticals: Pharma Sector Analysis FY24; Deregulation Improved Sales and Margins
Pakistan listed pharmaceuticals sector's earnings were up 70% YoY to Rs13.3bn in fiscal year 2024. This jump in profitability is...
837 Views
Topline Flash Note: Pakistan Strategy: MSCI November 2023 Index Review
MSCI released an update on its November 2023 Index Review, notifying that there is no change in constituents for Pakistan in the MSCI main...
532 Views
AGP Limited (AGP): Deregulation of drug prices and lower interest rates to lift earnings
AGP Limited (AGP) is one of the alpha stocks we recommended in our Strategy Report 2025 dated Nov 16, 2024. Our Dec-2025 Target Price of...
742 Views